Page last updated: 2024-08-23

vindesine and Neutropenia

vindesine has been researched along with Neutropenia in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19905 (20.83)18.7374
1990's14 (58.33)18.2507
2000's3 (12.50)29.6817
2010's2 (8.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brion, A; Chabin, M; Clavert, A; Colombat, P; Cumin, I; Delwail, V; Escoffre-Barbe, M; Gardembas, M; Ingrand, P; Lacotte-Thierry, L; Legouffe, E; Olivier, G; Solal-Celigny, P1
Gao, XN; Guo, YL; Han, XP; Jin, XS; Jing, Y; Liu, K; Yao, ZL; Yu, L; Zhang, R1
Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E1
Clark, GM; Sledge, GW; Von Hoff, DD1
Clark, GM; Griffin, C; Mattox, DE; Sledge, GW; Von Hoff, DD1
Broun, GO; Leavitt, J; Luedke, DW; Luedke, SL; Petruska, P; Reed, G1
Bedikian, AY; Bennetts, RW; Bodey, GP; Karlin, DA; Stroehlein, JR; Valdivieso, M1
Angus, B; Carey, P; Evans, RG; Jackson, GH; Lennard, AL; Lucraft, H; Proctor, SJ; Taylor, PR1
Bakker, PJ; Danner, SA; Kroon, FP; Meenhorst, PL; Muusers, A; Sprenger, HG; ten Napel, CH; van Leusen, R; Veenhof, CH1
Aoshiba, K; Konno, K; Nagai, A; Ueno, H1
Mori, K; Saitoh, Y; Tominaga, K1
Araki, J; Fujino, S; Fukuda, M; Hara, K; Itoh, N; Kanda, T; Kinoshita, A; Nakano, M; Oka, M; Sakamoto, A; Soda, H; Watanabe, K1
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K1
Eguchi, K; Fakuda, M; Kasai, T; Kurata, T; Ohe, Y; Oshita, F; Saijo, N; Shinkai, T; Tamura, T; Yamamoto, N1
Bastion, Y; Bosly, A; Coiffier, B; Dabouz-Harrouche, F; Deconinck, E; Dupriez, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Marit, G; Marolleau, JP; Reyes, F; Tilly, H; Yver, A1
Bréchot, JM; Chastang, C; L'Her, P; Lebas, FX; Lebeau, B; Leclerc, P; Meekel, P; Paillotin, D; Urban, T; Vincent, J1
Mizoguchi, H; Ohasi, Y; Takaku, F; Togawa, A; Toyama, K; Urabe, A1
Hirashima, K; Hotta, T; Kashimura, M; Ogawa, N; Sawamura, M; Sezaki, T; Takagi, T; Tsuchiya, J1
Miyazawa, N; Mori, K; Saito, Y; Tominaga, K; Yokoi, K1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Hasegawa, K; Kuriyama, T; Motomiya, M; Niitani, H; Ota, K; Takada, M; Tominaga, K1
Kamei, H; Kimura, I; Kodani, T; Ohnoshi, T; Ueoka, H1
Bartolucci, AA; Birch, R; Einhorn, L; Greco, FA; Luedke, DW; Omura, GA; Sarma, PR1
Armand, JP; Benhamed, M; Cvitkovic, E; Domenge, C; Guillot, T; Izzo, J; Recondo, G; Tellez-Bernal, E1
Copeland, LJ; Gershenson, DM; Kavanagh, JJ; Saul, PB; Wharton, JT1

Trials

14 trial(s) available for vindesine and Neutropenia

ArticleYear
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma. The GOELAMS LCP 99 trial.
    American journal of hematology, 2014, Volume: 89, Issue:11

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Immunocompetence; Infections; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Palliative Care; Prednisolone; Recurrence; Remission Induction; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Vindesine

2014
Autologous bone marrow transplantation in poor-risk high-grade non-Hodgkin's lymphoma in first complete remission. Newcastle and Northern Lymphoma Group.
    British journal of cancer, 1994, Volume: 70, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Bone Marrow Transplantation; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Prednisolone; Retrospective Studies; Risk Factors; Vincristine; Vindesine

1994
Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neutropenia; Prognosis; Prospective Studies; Recombinant Proteins; Sarcoma, Kaposi; Treatment Outcome; Vindesine

1995
Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neutropenia; Prospective Studies; Recombinant Proteins; Vindesine

1996
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Blood, 1996, Apr-15, Volume: 87, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine

1996
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Neutropenia; Prospective Studies; Remission Induction; Vindesine

1995
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Placebos; Recombinant Proteins; Survival Rate; Treatment Outcome; Vindesine

1997
A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Cancer, 1999, Oct-15, Volume: 86, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pulmonary Fibrosis; Radiotherapy; Radiotherapy Dosage; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vindesine

1999
[Clinical evaluation of rhG-CSF in patients with neutropenia induced by chemotherapy for multiple myeloma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2000, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Prednisolone; Treatment Outcome; Vindesine

2000
Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM).
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5

    Topics: Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Double-Blind Method; Female; Granulocyte Colony-Stimulating Factor; Humans; Japan; Lenograstim; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Nitrosourea Compounds; Prednisolone; Recombinant Proteins; Statistics, Nonparametric; Treatment Outcome; Vindesine

2001
Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:2

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Survival Analysis; Vindesine

1992
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neutropenia; Time Factors; Vindesine

1992
[Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:4 Pt 2

    Topics: Adenocarcinoma; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colony-Stimulating Factors; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Vindesine

1990
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chi-Square Distribution; Cisplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Multicenter Studies as Topic; Neutropenia; Prognosis; Proportional Hazards Models; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; United States; Vindesine

1990

Other Studies

10 other study(ies) available for vindesine and Neutropenia

ArticleYear
[Imatinib Combined with VP Low Dose Regiment for Treating Newly Diagnosed Adult Patients with Ph-positive ALL].
    Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Induction Chemotherapy; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Recurrence; Remission Induction; Transplantation, Homologous; Vindesine

2015
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine

2009
Phase II trial of vindesine in adenocarcinoma of the lung.
    Cancer treatment reports, 1984, Volume: 68, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nervous System; Neutropenia; Vinblastine; Vindesine

1984
Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
    American journal of clinical oncology, 1984, Volume: 7, Issue:3

    Topics: Aged; Carcinoma, Squamous Cell; Drug Evaluation; Head and Neck Neoplasms; Humans; Middle Aged; Neutropenia; Vinblastine; Vindesine

1984
Vindesine (VDS) monochemotherapy for non-small cell lung cancer: a report of 45 cases.
    Cancer treatment reports, 1982, Volume: 66, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nervous System; Neutropenia; Prognosis; Vinblastine; Vindesine

1982
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
    American journal of clinical oncology, 1982, Volume: 5, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Platelet Count; Prognosis; Rectal Neoplasms; Semustine; Thrombocytopenia; Vinblastine; Vindesine

1982
Transient neutropenia after intravenous injection of vindesine in patients with lung cancer.
    European journal of clinical pharmacology, 1994, Volume: 47, Issue:1

    Topics: Animals; Female; Humans; In Vitro Techniques; Leukocyte Count; Lung Neoplasms; Lymphocytes; Male; Middle Aged; Neutropenia; Neutrophils; Rats; Rats, Wistar; Vindesine

1994
Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Time Factors; Vindesine

1993
A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer.
    Cancer, 1990, Aug-15, Volume: 66, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Neutropenia; Recurrence; Remission Induction; Survival Rate; Vindesine

1990
Continuous-infusion vindesine in refractory carcinoma of the cervix: a phase II trial.
    Cancer treatment reports, 1985, Volume: 69, Issue:11

    Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Neutropenia; Uterine Cervical Neoplasms; Vindesine

1985